Opportunity Information: Apply for RFA 624 13 000005
Apply for RFA 624 13 000005
- The Ghana USAID Accra in the health sector is offering a public funding opportunity titled "Improving Malaria Care in Burkina Faso" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001 USAID Foreign Assistance for Programs Overseas.
- This funding opportunity was created on Apr 10, 2014 and posted on Jan 9, 2013.
- Applicants must submit their applications by Feb 26, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $15,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $15,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The "Improving Malaria Care in Burkina Faso" opportunity is a USAID/West Africa grant (run through the Regional Health Office based in Accra, Ghana) focused on reducing illness and deaths caused by malaria in Burkina Faso by scaling up interventions that are already proven to work. The project is designed to align closely with Burkina Faso's National Malaria Strategic Plan, meaning applicants are expected to support national priorities rather than introduce unrelated or experimental approaches. The program is structured around three main objectives: improving malaria prevention, improving malaria diagnosis and treatment, and strengthening the National Malaria Control Program (NMCP) so it can better plan, design, manage, coordinate, and oversee a comprehensive malaria control response over time.
The first objective, improving prevention, generally implies activities that expand or strengthen the coverage and correct use of preventive tools and behaviors endorsed in the national strategy. In practical terms, this often involves improving access to and use of insecticide-treated mosquito nets, supporting targeted prevention for vulnerable groups, improving community awareness and behavior change, and reinforcing systems that help prevention campaigns reach the right populations at the right time. Because the opportunity emphasizes "effective and proven interventions," it signals a preference for approaches with strong evidence in malaria control rather than novel pilots without a clear track record.
The second objective centers on diagnosis and treatment, which typically means ensuring that suspected malaria cases are tested appropriately and that confirmed cases receive effective treatment quickly and correctly. This kind of work commonly includes strengthening health facility and community-level testing capacity (for example, through rapid diagnostic tests and quality assurance), improving adherence to national treatment protocols, ensuring consistent availability and rational use of antimalarial medicines, and supporting supervision and training so providers can manage uncomplicated and severe cases properly. Efforts under this objective often also aim to reduce presumptive treatment where testing is available, improve referral systems, and strengthen reporting so program managers can see where gaps persist.
The third objective focuses on institutional capacity building for the NMCP, highlighting that USAID is not only funding service delivery improvements but also investing in the national program's ability to lead and coordinate malaria control. Capacity strengthening can include better planning and budgeting, improved supply chain oversight, stronger monitoring and evaluation systems, improved coordination with regional and district health teams, and clearer accountability for results. This element is especially important for sustainability, since it aims to leave behind stronger systems and management capabilities that continue after the award period ends.
From an administrative standpoint, this is a discretionary funding opportunity using a cooperative agreement, which usually means the recipient carries out the program but USAID remains substantially involved in oversight, technical direction, and collaboration during implementation. The opportunity anticipated a single award, with estimated total funding of up to $15,000,000 and an award ceiling of $15,000,000 (no stated minimum award amount). There is no cost sharing or matching requirement, which lowers barriers for applicants that may not have large amounts of non-federal funding to contribute. Eligibility is listed as unrestricted, meaning it is open to any type of entity as long as it meets the requirements described in the full announcement.
Key timeline details included a posting date of January 9, 2013, with an original closing date of February 14, 2013, later extended to February 26, 2013. The listing was archived on March 29, 2013. The opportunity is associated with CFDA 98.001 (USAID Foreign Assistance for Programs Overseas). For full announcement access and official guidance, the notice points applicants to Grants.gov and provides a contact for access issues: Mildred Agbo, Contracts Specialist (USAID Accra), phone +233 302 741464.
FAQs: Improving Malaria Care in Burkina Faso (USAID/West Africa)
What is the "Improving Malaria Care in Burkina Faso" grant opportunity?
It is a USAID/West Africa grant opportunity managed through the Regional Health Office in Accra, Ghana. The focus is to reduce illness and deaths caused by malaria in Burkina Faso by scaling up interventions that are already proven to work.
Who is running or managing this opportunity?
The opportunity is a USAID/West Africa funding opportunity run through the Regional Health Office based in Accra, Ghana.
Where will the funded work take place?
The program focus is Burkina Faso, with activities aimed at improving malaria prevention, diagnosis and treatment, and strengthening the National Malaria Control Program (NMCP) within Burkina Faso.
What is the main goal of the program?
The main goal is to reduce malaria-related illness and deaths in Burkina Faso by expanding coverage and performance of effective malaria interventions and strengthening national systems that support malaria control.
How is the program expected to align with Burkina Faso's national strategy?
The project is designed to align closely with Burkina Faso's National Malaria Strategic Plan. Applicants are expected to support national priorities rather than propose unrelated or experimental approaches.
What are the three main objectives of the opportunity?
The opportunity is structured around three objectives: (1) improving malaria prevention, (2) improving malaria diagnosis and treatment, and (3) strengthening the NMCP so it can better plan, design, manage, coordinate, and oversee a comprehensive malaria control response over time.
What kinds of activities fit under Objective 1 (improving malaria prevention)?
Prevention activities generally include expanding or strengthening coverage and correct use of preventive tools and behaviors endorsed in the national strategy. Examples described include improving access to and use of insecticide-treated mosquito nets, supporting targeted prevention for vulnerable groups, strengthening community awareness and behavior change, and reinforcing systems that help prevention campaigns reach the right populations at the right time.
Does the opportunity favor proven interventions over new pilots?
Yes. The opportunity emphasizes "effective and proven interventions," indicating a preference for approaches with strong evidence in malaria control rather than novel pilots without a clear track record.
What kinds of activities fit under Objective 2 (improving diagnosis and treatment)?
Diagnosis and treatment work typically includes ensuring suspected malaria cases are tested appropriately and confirmed cases receive effective treatment quickly and correctly. Activities described include strengthening facility and community testing capacity (such as rapid diagnostic tests and quality assurance), improving adherence to national treatment protocols, ensuring consistent availability and rational use of antimalarial medicines, and supporting training and supervision so providers can manage uncomplicated and severe cases properly.
Does the opportunity address presumptive treatment and referral systems?
Yes. Efforts under the diagnosis and treatment objective often aim to reduce presumptive treatment where testing is available, improve referral systems, and strengthen reporting so program managers can identify gaps.
What kinds of activities fit under Objective 3 (strengthening the NMCP)?
The third objective is institutional capacity building for the NMCP. The opportunity highlights strengthening the NMCP's ability to lead and coordinate malaria control, including better planning and budgeting, improved supply chain oversight, stronger monitoring and evaluation systems, improved coordination with regional and district health teams, and clearer accountability for results.
Why is NMCP capacity strengthening a key part of this opportunity?
This element is presented as important for sustainability because it aims to leave behind stronger systems and management capabilities that can continue after the award period ends.
What type of funding instrument is used?
This is a discretionary funding opportunity using a cooperative agreement.
What does a cooperative agreement imply for implementation?
A cooperative agreement generally means the recipient carries out the program, while USAID remains substantially involved in oversight, technical direction, and collaboration during implementation.
How many awards were anticipated?
The opportunity anticipated a single award.
What is the estimated total funding amount?
The estimated total funding is up to $15,000,000.
What is the award ceiling?
The award ceiling is $15,000,000.
Is there a minimum award amount stated?
No minimum award amount is stated in the information provided.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is listed as unrestricted, meaning it is open to any type of entity as long as it meets the requirements described in the full announcement.
Where can applicants find the full announcement and official guidance?
The notice directs applicants to Grants.gov for full announcement access and official guidance.
What are the key dates for this opportunity?
The posting date was January 9, 2013. The original closing date was February 14, 2013, and it was later extended to February 26, 2013. The listing was archived on March 29, 2013.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA 98.001 (USAID Foreign Assistance for Programs Overseas).
Who should be contacted for access issues related to the announcement?
For access issues, the notice lists Mildred Agbo, Contracts Specialist (USAID Accra), phone +233 302 741464.
Browse more opportunities from the same category: Health
Next opportunity: Behavioral Integrative Treatment Development Program (R34)
Previous opportunity: Collaborative Center for Aeronautical Sciences
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA 624 13 000005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA 624 13 000005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Indoor Environment of Low Income Renovated Multifamily Housing in the Western Region of the United States Apply for RFA EH 13 001 Funding Number: RFA EH 13 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Life Course Research Network Apply for HRSA 13 173 Funding Number: HRSA 13 173 Agency: Health Resources and Services Administration Category: Health Funding Amount: $150,000 |
| Emergency Medical Services for Children Targeted Issues Demonstration Projects Apply for HRSA 13 181 Funding Number: HRSA 13 181 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Monitoring cause specific school absenteeism for estimating community wide influenza transmission Apply for RFA CK 13 003 Funding Number: RFA CK 13 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Statewide Family Network Program Apply for SM 13 003 Funding Number: SM 13 003 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $60,000 |
| Initiative for Maximizing Student Development (IMSD) (R25) Apply for PAR 13 082 Funding Number: PAR 13 082 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Postbaccalaureate Research Education Program (PREP) (R25) Apply for PAR 13 085 Funding Number: PAR 13 085 Agency: National Institutes of Health Category: Health Funding Amount: $375,000 |
| Nursing Workforce Diversity (NWD) Program Apply for HRSA 13 191 Funding Number: HRSA 13 191 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Research and Technical Assistance for Public Health Interventions in Haiti to support post earthquake reconstruction, cholera and HIV/AIDS Apply for RFA GH 13 006 Funding Number: RFA GH 13 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Research Grants for Preventing Violence and Violence Related Injury Apply for RFA CE 13 002 Funding Number: RFA CE 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Delivering Therapeutics to Residual Active HIV Reservoirs (R01) Apply for RFA AI 12 042 Funding Number: RFA AI 12 042 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovation for HIV Vaccine Discovery (R01) Apply for RFA AI 13 007 Funding Number: RFA AI 13 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technical assistance in support of clinical training and mentoring for HIV treatment and prevention services in the Republic of Zimbabwe under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1329 Funding Number: CDC RFA GH13 1329 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $6,900,000 |
| Scaling up Voluntary Medical Male Circumcision through improvements in the availability, integration and quality of HIV prevention, care and treatment services in Zimbabwe under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1328 Funding Number: CDC RFA GH13 1328 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $12,000,000 |
| Support Services from the World Health Organization (WHO) for the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1327 Funding Number: CDC RFA GH13 1327 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $15,000,000 |
| Autoimmunity Centers of Excellence, Basic Research Program (U19) Apply for RFA AI 12 060 Funding Number: RFA AI 12 060 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Autoimmunity Centers of Excellence, Clinical Research Program (UM1) Apply for RFA AI 12 059 Funding Number: RFA AI 12 059 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Family Planning and Reproductive Health Methods APS Apply for SOL OAA 13 000024 Funding Number: SOL OAA 13 000024 Agency: Agency for International Development Category: Health Funding Amount: $80,000,000 |
| Statewide Consumer Network Grant Apply for SM 13 004 Funding Number: SM 13 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $70,000 |
| Implementing Public Health Programs and Strengthening Public Health Capacity in Guatemala and Central American Apply for CDC RFA GH13 1306 Funding Number: CDC RFA GH13 1306 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA 624 13 000005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.